Clinical Trials Sponsored by The Novartis Foundation

Total 2589 results

Centre Hospitalier Universitaire Vaudois
The Novartis Foundation

Recruiting

Primary Hyperparathyroidism and Gut Microbiota (HYPOGEUM)

Hyperparathyroidism, Primary

Switzerland
GOG Foundation
Novartis

Recruiting

A Study of Alpelisib and Fulvestrant to Treat Endometrial Cancer

Endometroid Endometrial Cancer

United States
PETHEMA Foundation
Novartis

Completed

A Retrospective Epidemiologic Registry to Gain Insight Into the Characteristics and Prognosis of AML Patients According to the Routinely Used Genetic and Biologic Markers

Acute Myeloid Leukemia

Spain
NYU Langone Health
Novartis Pharmaceuticals; The Children's Tumor Foundation

Completed

Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

Neurofibromatosis Type II

United States
Novartis Pharmaceuticals
Alliance Foundation Trials, LLC.; RTOG Foundation, Inc.

Active, not recruiting

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC (PSMAddition)

Prostatic Neoplasms

United States, China, Canada, Spain, United Kingdom, Belgium, Japan, Taiwan, Germany, Singapore, Austria, Netherlands, Korea, Republic of, France, Switzerland, Denmark, Sweden, Poland, Czechia
Novartis Pharmaceuticals
The Cleveland Clinic

Completed

Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients (AQUARIUS)

Coronary Artery Disease (CAD) | Coronary Atherosclerosis

Italy, Spain, Hungary, Australia, United States, Belgium, Canada, Germany, France, Argentina, Poland
GOG Foundation
Novartis Pharmaceuticals

Active, not recruiting

Everolimus and Letrozole or Hormonal Therapy to Treat Endometrial Cancer

Advanced, Persistent, or Recurrent Endometrial Cancer

United States
The Cleveland Clinic
Novartis

Completed

Canakinumab in Covid-19 Cardiac Injury (The Three C Study)

COVID-19 | SARS-CoV 2

United States
The Cleveland Clinic
Novartis

Completed

Safety and Efficacy Study of Concomitant Radiotherapy and Zoledronic Acid for Bone Metastases Palliation

Breast Cancer | Lung Cancer | Prostate Cancer | Bone Metastases
UNICANCER
Novartis; Fondation ARC

Completed

Molecular Alterations Associated With Resistance to Endocrine Therapy and Impacting Treatment With mTOR Inhibitor (SAFIR-TOR)

Metastatic Breast Cancer

France
Novartis Pharmaceuticals
Novartis is the Marketing Authorization Holder for Jakavi outside the US.

No longer available

Ruxolitinib Managed Access Program (MAP) for Patients Diagnosed With Severe/Very Severe COVID-19 Illness

Severe/Very Severe COVID-19 Illness
PETHEMA Foundation
Novartis; Dynamic Solutions

Completed

Zoledronic Acid in Patients With Multiple Myeloma and Asymptomatic Biochemical Relapse (AZABACHE)

Multiple Myeloma

Spain
The Queen Elizabeth Hospital King's Lynn NHS Foundation...
Novartis Pharmaceuticals

Not yet recruiting

Efficacy of a Streamlined Heart Failure Optimization Protocol (SHORT)

Chronic Heart Failure | Heart Failure With Reduced Ejection Fraction

United Kingdom
Henry M. Jackson Foundation for the Advancement...
Novartis

Completed

Gleevec and Gemzar in Patients With Epithelial Ovarian Cancer

Ovarian Cancer | Primary Peritoneal Cancer

United States
The Cleveland Clinic
Novartis Pharmaceuticals

Completed

Gilenya's Impact on Cognitive Function and Thalamic Volumes

Multiple Sclerosis

United States
The Metis Foundation

Recruiting

Pilot Study: KeraStat® Gel for Topical Delivery of Morphine for Management of Non-Healing, Painful Open Wounds and Ulcers

Burns | Wound of Skin

United States
The Geneva Foundation

Terminated

The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) Pediatric Patients

Obesity, Childhood | Hemosiderosis | Liver Steatosis | Steatohepatitis, Nonalcoholic | Overweight Adolescents

United States
The Heartburn Foundation

Active, not recruiting

Registry of Outcomes From AntiReflux Surgery (ROARS)

Hiatal Hernia | Gastroesophageal Reflux Disease

United States
The Metis Foundation

Completed

A Case Series Study of Negative Pressure Platform Wound Device (NP-PWD)

Incisions, Surgical

United States
The Hawkins Foundation

Completed

Suture Anchor Comparison in Rotator Cuff Repairs

Rotator Cuff Injury

United States
The Hawkins Foundation

Completed

Telemedicine in Total Hip Arthroplasty and Total Knee Arthroplasty

Knee Osteoarthritis | Hip Osteoarthritis

United States
The Hawkins Foundation

Completed

Topical Tranexamic Acid (TXA) in Joint Arthroplasty

Osteoarthritis | Hip Arthropathy | Shoulder Arthropathy

United States
The Hawkins Foundation

Completed

Hip Scope Fascia-iliaca (FI) Block Study

Acetabular Labrum Tear | Hip Dysplasia | Femoroacetabular Impingement

United States
The Cleveland Clinic
Novartis Pharmaceuticals

Completed

Intervenous (IV) Zoledronic Acid After Forteo in Postmenopausal Women

Osteoporosis

United States
Novartis
The TIMI Study Group

Completed

Efficacy and Safety of Aliskiren and Valsartan Versus Placebo in Patients Stabilized Following an Acute Coronary Syndrome

Myocardial Ischemia | Post Acute Coronary Syndrome

Germany, Spain, United States, Belgium, Canada, Czech Republic, Hungary, Netherlands, Poland, Russian Federation, Sweden
The Metis Foundation

Not yet recruiting

Suprathel® Use During Prolonged Field Care to Promote Healing and Reduce the Need for Grafting of Burn Wounds

Burns | Wound of Skin
The Metis Foundation

Not yet recruiting

Microscopic Skin Tissue Column Grafting Technique Using the Autologous Regeneration of Tissue System

Burns | Wound of Skin
The Metis Foundation

Not yet recruiting

Sperry Micro-Coring System: Automated Full-Thickness Skin Microcolumns in Dermal Regeneration Templates for 'Donor-Free' Skin Renewal

Burns | Wound of Skin
The Hawkins Foundation

Not yet recruiting

Driving After Shoulder Surgery

Shoulder
The Metis Foundation

Completed

The Use of a Platform Wound Device for Reducing Infection

Burn Wound | Wounds and Injury | Infection Wound

United States
The Camelot Foundation

Completed

The Fleming [FMTVDM] Directed CoVid-19 Treatment Protocol (FMTVDM)

CoVid 19 Positive

United States
The Hawkins Foundation

Completed

Sport Cord Test Following ACL Reconstruction

Injury of Anterior Cruciate Ligament

United States
The Hawkins Foundation

Withdrawn

Exparel vs Exparel Plus ACB in TKAs

Knee Osteoarthritis

United States
The Orthopedic Foundation

Completed

Clinical Study of Ingrezza (Valbenazine) for the Treatment of Cervical Dystonia

Cervical Dystonia

United States
The Geneva Foundation

Terminated

The Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Adults (PREV)

Non-Alcoholic Fatty Liver Disease | Non Alcoholic Steatohepatitis

United States
The Hawkins Foundation

Terminated

3D Modeling to Improve Hip Arthroscopy Outcomes

Femoroacetabular Impingement

United States
The Hawkins Foundation

Completed

Pediatric Distal Radius US Study

Distal Radius Fractures

United States
The Hawkins Foundation

Terminated

Visionaire: A Prospective Study

Osteoarthritis

United States
The Hawkins Foundation

No longer available

HUD: PIP Joint Implant

Arthrosis | Osteoarthrosis
The Ojai Foundation

Completed

Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+

HIV Seropositivity

Mali
University of California, San Francisco
Novartis; amfAR, The Foundation for AIDS Research

Completed

Impact of Everolimus on HIV Persistence Post Kidney or Liver Transplant (HIVTR-EVE)

HIV | Liver Transplant | Kidney Transplant

United States
Hospital Authority, Hong Kong
Novartis Pharmaceuticals; The Hong Kong Blood Cancer Foundation

Unknown

Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation | Graft vs Host Disease

China
UNICANCER
Novartis; Breast Cancer Research Foundation

Recruiting

Detection of Tumor DNA in the Blood of Patients Receiving Standard Therapy for Hormone Receptor-positive (HR+) Non-HER2 Expressing (HER2-) Metastatic Breast Cancer as a Tool to Select Those Who May Benefit From the Next Course of Fulvestrant in Combination With Alpelisib or Ribociclib (SAFIR 03)

Breast Cancer Stage IV

France
University Hospital, Basel, Switzerland
Novartis; ProPatient foundation of the University Hospital Basel

Completed

Electronic Patient-reported Outcome Monitoring in Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria (ePRO-AA-PNH)

Aplastic Anemia | Paroxysmal Nocturnal Hemoglobinuria

Switzerland
Gynecologic Oncology Group
Novartis

Active, not recruiting

Ribociclib and Letrozole Treatment in Ovarian Cancer

Low Grade Serous Carcinoma

United States
Medical Research Foundation, The Netherlands
Langerhans Foundation, the Netherlands

Completed

Effect of Self-monitoring of Blood Glucose in Patients With Type 2 Diabetes Mellitus Not Using Insulin

Diabetes Mellitus, Type 2

Netherlands
Karolinska Institutet
The Solstickan Foundation, The Sven Jerring Foundation

Completed

Evaluation of the Parental Support Intervention For Our Children's Sake in Prisons in Sweden

Parent-Child Relations | Parenting

Sweden
Montefiore Medical Center
The Purjes Foundation; The Greenbaum Foundation

Recruiting

The Impact of Dietary Pattern on Erectile Function (ERECTION)

Erectile Dysfunction

United States
Cambridge Health Alliance
The Arnold P. Gold Foundation; The Arthur Vining Davis Foundations

Completed

MINDFUL-PC: Integrating Mindfulness Into the Patient-Centered Medical Home (MINDFUL-PC)

Depression | Anxiety | Adjustment Disorder | Stress Related Disorder

United States
The Cleveland Clinic
The Huron Foundation

Completed

Impact on Patient COmpliance With Medication Using Pre-packaged Blisters for Long-term Medical therapY (I-COMPLY)

Medication Adherence | Medication Compliance

Clinical Trials Sponsored by The Novartis Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations